Streetbeat News

Products Services

DGX

Sentara Health Plans and Quest Diagnostics have announced a strategic collaboration, making Quest the exclusive independent lab provider for Sentara members in Virginia and Florida.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 12:54 pm

VTAK

Catheter Precision, Inc. (NYSE:VTAK) has signed a distribution agreement with Dubai's Forum Medical to expand the distribution of its product, LockeT, to the Middle East, including Georgia, Uzbekistan, and Kazakhstan.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 12:53 pm

BABA

Alibaba has signed a five-year cloud service deal with Indonesia's GoTo Group, agreeing not to divest its stake in the company during this period. The deal comes as Alibaba faces challenges from domestic competition and U.S. sanctions. GoTo is currently unprofitable and has been restructuring.

Portfolio Pulse from Anusuya Lahiri

September 18, 2024 | 12:46 pm

FEMY

Femasys is expanding its reach by onboarding infertility medical clinic customers in California and Florida to offer its Femaseed infertility treatment. This move could potentially increase the company's market presence and revenue.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 12:37 pm

RCI

Rogers Communications has signed an agreement to purchase Bell's 37.5% ownership stake in Maple Leaf Sports & Entertainment (MLSE) for C$4.7 billion. This acquisition will allow Rogers to invest in bringing championships to Canada. Sportsnet, owned by Rogers, will continue broadcasting 50% of Maple Leafs and Raptors games controlled by MLSE.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 12:35 pm

VEEA

Veea and Crowdkeep have announced a partnership to integrate their technologies. This collaboration aims to enhance the capabilities of both companies by combining Veea's edge computing platform with Crowdkeep's workforce management solutions. The integration is expected to provide improved services to their clients.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 12:32 pm

SONN

Sonnet BioTherapeutics has completed enrollment for its Phase 1 study of SON-1010, a targeted immune activation therapy for solid tumors. The company expects topline safety data by Q4 2024.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 12:32 pm

ORKT

Orangekloud has signed a Memorandum of Understanding (MOU) with JPJ Medical to distribute its SaaS solutions in South Africa's healthcare sector as a white-labeled OEM solution. This partnership aims to expand Orangekloud's market presence in the healthcare industry.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 12:32 pm

ANIX

Anixa Biosciences is scheduled to present at the International Gynecologic Cancer Conference on September 25 at 3:00 p.m. ET. This event could provide insights into their ongoing research and developments in cancer treatment.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 12:31 pm

CBOE

The Swiss stock exchange SIX is considering launching a cryptocurrency trading platform in Europe, aiming to compete with established digital asset firms. This move reflects growing institutional interest in digital assets, leveraging Switzerland's robust regulatory framework.

Portfolio Pulse from Murtuza Merchant

September 18, 2024 | 12:27 pm